Search for: "Mylan Pharmaceuticals"
Results 41 - 60
of 738
Sorted by Relevance
|
Sort by Date
2 Sep 2016, 6:00 am
Mylan Pharmaceuticals received a huge amount of press in the United States recently. [read post]
2 Aug 2023, 11:05 am
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
31 Dec 2010, 3:57 am
Mylan has been sued by several other states, and last year pharmaceutical companies Mylan, AstraZeneca, and Johnson & Johnson agreed to pay $124 million in settlement of claims that the companies violated the U.S. [read post]
13 May 2021, 11:44 pm
Ebenezer Scrooge and Marley's GhostJane LambertPatents Court (Mr Justice Matcus Smith) Neurim Pharmaceuticals (1991) Ltd and Another v Generics UK Ltd (t/a Mylan) and another [2021] EWHC 530 (Pat) (12 March 2021)This was an action by Neurim Pharmaceuticals (1991) Ltd ("Neurim") the proprietor of European patent (UK) 1 441 702 B1 and Flynn Pharma Ltd ("Flynn"), its purported exclusive licensee, [read post]
27 Jun 2017, 7:56 am
Pricing information has yet to be released to the public, but the company anticipates Symjepi will be priced well below Mylan’s outrageously over-priced EpiPen. [read post]
21 Sep 2016, 8:54 am
WASHINGTON — The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. [read post]
8 Nov 2021, 9:15 am
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
9 Apr 2008, 8:49 pm
Mylan Laboratories, Inc. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
18 May 2014, 8:42 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
8 Aug 2009, 1:43 am
A Texas law firm is targeting generic drug giant Mylan Inc., along with other pharmaceutical companies, in product liability lawsuits related to the manufacture of pain patches. [read post]
17 Dec 2010, 7:47 am
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
16 Mar 2021, 1:15 pm
In 2019, Janssen Pharmaceuticals sued Mylan Laboratories in district court for infringing U.S. [read post]
13 Oct 2014, 8:46 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc.; Natco Pharma Ltd. [read post]
13 Feb 2011, 9:08 pm
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
23 Feb 2011, 6:27 am
Noven, located in Miami and a subsidiary of Hisamitsu Pharmaceutical Co. , has filed a Hatch-Waxman suit against Mylan related to Mylan's proposed generic equivalent of Vivelle-Dot, a transdermal patch used to treat the symptoms associated with menopause.Back in the day, victorious Pittsburgh Pirates from the World Series of 1960 invested in Mylan. [read post]
27 Jul 2018, 6:00 am
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
29 Sep 2022, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
20 Jan 2022, 4:19 am
In denying petitions from consumer tech giant Apple and generic pharmaceutical firm Mylan Laboratories, SCOTUS has ended the latest challenge to the PTAB’s NHK/Fintiv rule, which has raised... [read post]
29 Sep 2022, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
